Facioscapulohumeral Muscular Dystrophy (FSHD) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy
Condition: Facioscapulohumeral Muscular Dystrophy (FSHD) Interventions: Drug: Placebo; Drug: RO7204239 Sponsor: Hoffmann-La Roche Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2022 Category: Research Source Type: clinical trials
